Back to top

Rydex Srs Trust Biotechnology Fd: (MF: RYOIX)

(MF) As of Apr 17, 2014 06:06 PM ET

 Add to portfolio

$62.90 USD

-0.27 (-0.43%)

Zacks MF Rank : 5 - Strong Sell [?]         5

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Mar 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Mar 31, 2014) 6.93
Objective* Equity - Sector Health
Peer* HL MG

*Key

Zacks Premium Research for RYOIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Strong Sell 5
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 44.63
Net Assets (Mil $) 3/31/2014 275.52
%Turnover 3/31/2014 197.00

Allocation

% of Portfolio
Large Growth 18.99
Large Value 0.00
Small Growth 0.00
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 37.31
High Yield Bond 0.00

Sector / Country Weightings

As of 3/31/2014 % of Portfolio
Health 57.66
Services 22.07
Other 6.75
Technology 6.47
Industrial Cyclical 5.69
Non-Durable 1.36

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2013)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 7.42 28.07
AMGEN INC 6.54 24.77
CELGENE CORP 5.93 22.46
BIOGEN IDEC INC 5.69 21.52
REGENERON PHARMACEUTICALS 3.72 14.10
ALEXION PHARMACEUTICALS I 3.55 13.45
VERTEX PHARMACEUTICALS IN 2.89 10.93
ILLUMINA INC 2.66 10.08
LIFE TECHNOLOGIES CORP 2.53 9.57

Stock Holding % of Net Assets

As Of 12/31/2013
Total Issues 66
Avg. P/E 43.06
Avg. P/Book 5.71
Avg. EPS Growth 16.13
Avg. Market Value (Mil $) 28,318

Risk

3 Year 5 Year 10 Year
Beta 0.95 0.90 0.86
Alpha 18.42 9.83 6.86
R Squared 0.32 0.36 0.39
Std. Dev. 21.19 21.05 20.50
Sharpe 1.68 1.49 2.00